earnings season

Elston’s Bruce Williams discuss ResMed's results and margin momentum, and whether the stock still deserves a buy rating.

Telstra’s (ASX:TLS) latest half-year financial results, released yesterday, tell a story of modest gains, underpinned by cost control rather than broad-based...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse a handful of stocks that could surprise in August.

Plus, a closer look at how two of Livewire's most recognisable growth and value fund managers are investing.

10 of 11 major ASX sectors finished higher in a broad-based rally. Property and gold stocks led as the lithium short squeeze continues...

All the important stuff that happened on the Australian stock market today, all in one place.

Major brokers appreciated the strength of Fortescue's first half result, but it wasn’t enough to sway their prevailing bearish views.

It was another big day under the surface! While the S&P/ASX 200 gained just 0.12%, there were several massive earnings related moves.

All the important stuff that happened on the Australian stock market today, all in one place.